W. A. J. Starmans et al. / Tetrahedron: Asymmetry 9 (1998) 429–435
433
21.6 (t, CH2). IR (CHCl3): σ 1720 (s, COOCH3). GC–MS: m/z 236 (M++1), 176 (M+−COOCH3), 121
(methoxytropilium). HR–MS: calculated for C13H17NO3 235.12084, found 235.12027.
4.6. (ꢁ)-Methyl 1-allylazetidine-2-carboxylate 2c
1
Yield: 64%. Bp.: 47–48°C (1.0 mmHg). H NMR (400 MHz, CDCl3): δ 5.86–5.75 (m, 1H,
CH2CH=CH2), 5.20 and 5.11 (d, 17.1 Hz, and d, J=10.1 Hz, 2H, CH2CH=CH2), 3.73 (s, 3H, COOCH3),
3.66 (t, J=8.5 Hz, 1H, NCH), 3.38 and 2.90 (dt, J=2.5 Hz and J=7.5 Hz, and q, J=8.0 Hz, 2H, NCH2),
3.26 and 3.07 (dd, J=6.4 Hz and 12.9 Hz, and dd, J=6.7 Hz and J=12.9 Hz, 2H, CH2CH=CH2), 2.40–2.31
and 2.27–2.20 (m and m, 2H, CH2). 13C NMR (400 MHz, CDCl3): δ 172.8 (s, C(O)O), 133.4 (d,
CH2CH=CH2), 117.5 (t, CH2CH=CH2), 64.0 (d, NCH), 61.0 (t, CH2CH=CH2), 51.4 (q, COOCH3),
50.2 (t, NCH2), 21.3 (t, CH2). IR (CHCl3): σ 1718 (s, COOCH3). GC–MS: m/z 156 (M++1), 96
(M+−COOCH3). HR–MS: calculated for C8H13NO2 155.09463, found 155.09416.
4.7. (ꢁ)-Methyl 1-benzhydrylazetidine-2-carboxylate 2d
Yield: 50%. Bp.: 130°C (0.1 mmHg). 1H NMR (CDCl3): δ 7.52–7.09 (m, 10H, aromatic benzhydryl),
4.46 (s, 1H, benzylic CH), 3.72 (t, J=8.1 Hz, 1H, NCH), 3.50–3.34 (m, 1H, NCH2), 3.34 (s, 3H,
COOCH3), 2.90 (dt, J=7.7 Hz and J=8.4 Hz, 1H, NCH2), 2.49–2.0 (m, 2H, CH2). 13C NMR (CDCl3): δ
172.9 (s, C(O)O), 141.4, 141.2 (s, aromatic C), 128.5, 128.3, 128.2, 127.5, 127.2 (d, aromatic C), 77.5
and 64.6 (d, CHPh2 and NCH), 51.4 (q, COOCH3), 51.4 (t, NCH2), 20.9 (t, CH2). IR (CHCl3): σ 1715
(s, COOCH3). GC–MS: m/z 282 (M++1), 222 (M+−COOCH3), 167 (Ph–CH+–Ph). HR–MS: calculated
for C18H19NO2 281.14158, found 281.14091.
4.8. General procedure for the synthesis of racemic azetidine carboxamides
A solution of azetidine ester 2 (4.87 mmol) in concentrated aqueous ammonia (20 ml) was stirred for
3 h and then extracted three times with chloroform to provide the corresponding carboxamide as a white
solid.
4.9. (ꢁ)-1-Benzylazetidine-2-carboxamide 3a
1
Yield: 81%. Mp.: 104–105°C (ethanol (96%)). H NMR (CD3OD): δ 7.24 (s, 5H, Ph), 4.92 (t, J=9.2
Hz, 1H, NCH), 4.20 (s, 2H, benzylic CH2), 3.97 and 3.73 (t, J=9.4 Hz, and dt, J=4.3 Hz and J=9.5 Hz, 2H,
NCH2), 2.8–2.15 (m, 2H, CH2). IR (CCl4): σ 3500 and 3430 (s, NH2 amide), 1685 (s, CO amide), 700
(s, monosubstituted phenyl). GC–MS: m/z 191 (M++1), 146 (M+−CO(NH2)), 91 (tropilium). Elemental
analysis: calculated for C11H14N2O % C 69.45, % H 7.42, % N 14.72. Found % C 69.43, % H 7.10, %
N 14.45.
4.10. (ꢁ)-1-(4-Methoxybenzyl)azetidine-2-carboxamide 3b
1
Mp.: 109.5–111°C. H NMR (CDCl3): δ 7.18 (d, Jortho=8.6 Hz, 2H, aromatic), 6.84 (d, Jortho=8.6
Hz, 2H, aromatic), 5.71 (broad s, CONH2), 3.79 (s, 3H, OCH3), 3.78 (t, J=9 Hz, 1H, NCH), 3.57 (d,
J=4.5 Hz, 2H, benzylic CH2), 3.33 and 3.49 (dt, J=2.5 Hz and J=7.8 Hz, and dt, J=7.6 Hz and J=7.9 Hz,
2H, NCH2), 2.55–2.04 (m, 2H, CH2). 13C NMR (CDCl3): δ 176.5 (s, CONH2), 129.6 (d, aromatic C),
129.4 (s, aromatic C), 114.0 (d, aromatic C), 66.0 (d, NCH), 61.7 (t, benzylic CH2), 55.3 (q, OCH3),